BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25885821)

  • 21. Screen-and-treat approach to cervical cancer prevention using visual inspection with acetic acid and cryotherapy: experiences, perceptions, and beliefs from demonstration projects in Peru, Uganda, and Vietnam.
    Paul P; Winkler JL; Bartolini RM; Penny ME; Huong TT; Nga le T; Kumakech E; Mugisha E; Jeronimo J
    Oncologist; 2013; 18 Suppl():6-12. PubMed ID: 24334477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Single-Visit Approach as a Cervical Cancer Prevention Strategy Among Women With HIV in Ethiopia: Successes and Lessons Learned.
    Shiferaw N; Salvador-Davila G; Kassahun K; Brooks MI; Weldegebreal T; Tilahun Y; Zerihun H; Nigatu T; Lulu K; Ahmed I; Blumenthal PD; Asnake M
    Glob Health Sci Pract; 2016 Mar; 4(1):87-98. PubMed ID: 27016546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a single-visit approach to cervical cancer screening and treatment in Guyana: feasibility, effectiveness and lessons learned.
    Martin CE; Tergas AI; Wysong M; Reinsel M; Estep D; Varallo J
    J Obstet Gynaecol Res; 2014 Jun; 40(6):1707-16. PubMed ID: 24888938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expanding the Single-Visit Approach for Cervical Cancer Prevention: Successes and Lessons From Burkina Faso.
    Ouedraogo Y; Furlane G; Fruhauf T; Badolo O; Bonkoungou M; Pleah T; Lankoande J; Bicaba I; Bazant ES
    Glob Health Sci Pract; 2018 Jun; 6(2):288-298. PubMed ID: 29959272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized trial comparing the diagnostic accuracy of visual inspection with acetic acid to Visual Inspection with Lugol's Iodine for cervical cancer screening in HIV-infected women.
    Huchko MJ; Sneden J; Zakaras JM; Smith-McCune K; Sawaya G; Maloba M; Bukusi EA; Cohen CR
    PLoS One; 2015; 10(4):e0118568. PubMed ID: 25849627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical cancer screening and treatment, HIV infection, and age: Program implementation in seven regions of Namibia.
    Korn AK; Muzingwani L; O'Bryan G; Ensminger A; Boylan AD; Kafidi EL; Kashali M; Ashipala L; Nitschke AM; Dziuban EJ; Forster N; Eckert LO; O'Malley G
    PLoS One; 2022; 17(2):e0263920. PubMed ID: 35171941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial.
    Pinder LF; Parham GP; Basu P; Muwonge R; Lucas E; Nyambe N; Sauvaget C; Mwanahamuntu MH; Sankaranarayanan R; Prendiville W
    Lancet Oncol; 2020 Jan; 21(1):175-184. PubMed ID: 31734069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of visual inspection with acetic acid plus cryotherapy "see and treat" approach on the reduction of the population burden of cervical preinvasive lesions in Southeast Nigeria.
    Chigbu CO; Onyebuchi AK; Nnakenyi EF; Egbuji CC
    Niger J Clin Pract; 2017 Feb; 20(2):239-243. PubMed ID: 28091444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
    Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
    [No Abstract]   [Full Text] [Related]  

  • 31. High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot study.
    Reddy D; Njala J; Stocker P; Schooley A; Flores M; Tseng CH; Pfaff C; Jansen P; Mitsuyasu RT; Hoffman RM
    Int J STD AIDS; 2015 May; 26(6):379-87. PubMed ID: 24928579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Higher educational attainment associated with reduced likelihood of abnormal cervical lesions among Zambian women - a cross sectional study.
    Hamoonga TE; Likwa RN; Musonda P; Michelo C
    BMC Cancer; 2017 Oct; 17(1):681. PubMed ID: 29029626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening of cervical neoplasia in HIV-infected women in India.
    Joshi S; Sankaranarayanan R; Muwonge R; Kulkarni V; Somanathan T; Divate U
    AIDS; 2013 Feb; 27(4):607-15. PubMed ID: 23079814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia.
    Parham GP; Sahasrabuddhe VV; Mwanahamuntu MH; Shepherd BE; Hicks ML; Stringer EM; Vermund SH
    Gynecol Oncol; 2006 Dec; 103(3):1017-22. PubMed ID: 16875716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for cervical neoplasia in Bangladesh using visual inspection with acetic acid.
    Nessa A; Hussain MA; Rahman JN; Rashid MH; Muwonge R; Sankaranarayanan R
    Int J Gynaecol Obstet; 2010 Nov; 111(2):115-8. PubMed ID: 20674919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. eC3--a modern telecommunications matrix for cervical cancer prevention in Zambia.
    Parham GP; Mwanahamuntu MH; Pfaendler KS; Sahasrabuddhe VV; Myung D; Mkumba G; Kapambwe S; Mwanza B; Chibwesha C; Hicks ML; Stringer JS
    J Low Genit Tract Dis; 2010 Jul; 14(3):167-73. PubMed ID: 20592550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical performance of digital cervicography and cytology for cervical cancer screening in HIV-infected women in Lusaka, Zambia.
    Bateman AC; Parham GP; Sahasrabuddhe VV; Mwanahamuntu MH; Kapambwe S; Katundu K; Nkole T; Mulundika J; Pfaendler KS; Hicks ML; Shibemba A; Vermund SH; Stringer JS; Chibwesha CJ
    J Acquir Immune Defic Syndr; 2014 Oct; 67(2):212-5. PubMed ID: 24977474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection.
    Nieves L; Enerson CL; Belinson S; Brainard J; Chiesa-Vottero A; Nagore N; Booth C; Pérez AG; Chávez-Avilés MN; Belinson J
    Int J Gynecol Cancer; 2013 Mar; 23(3):513-8. PubMed ID: 23334437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical determinants of a positive visual inspection after treatment with acetic acid for cervical cancer screening.
    Castle PE; Qiao YL; Zhao FH; Chen W; Valdez M; Zhang X; Kang LN; Bansil P; Paul P; Bai P; Peck R; Li J; Chen F; Jeronimo J
    BJOG; 2014 May; 121(6):739-46. PubMed ID: 24575872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.